Hope For The Future
Every Day, Progress Is Made
Thousands of scientists all over the world are actively involved in Alzheimer's research. This research spans from clinical trials, exploring preventive measures, identifying new treatments, and more.
Recent Breakthroughs
Blood Test
In May 2025, the FDA approved the first blood test to aid in diagnosing Alzheimer's disease. The blood test, called Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, is intended to detect amyloid plaques in adults ages 55 and over exhibiting signs of the disease. This breakthrough can assist in diagnosis, potentially allowing for earlier treatment.
​
Two Treatments
In 2023 and 2024 the FDA approved two monoclonal antibodies that target and remove amyloid beta proteins in the brain. These two treatments, known as lecanemab and donanedab, are intended for patients with early-stage Alzheimer's. While this is a huge breakthrough in Alzheimer's disease research, it is crucial to know that these treatments only slow the disease's progression and are not a cure.
Stem Cell Therapy
Stem cell therapy is an experimental approach that aims to repair or replace damaged brain cells in Alzheimer's patients using stem cells. Scientists believe that this therapy may be able to halt the progression of Alzheimer's. Currently, multiple clinical trials are underway to examine the treatment and assess the long-term safety of stem cell therapy for Alzheimer's disease.